report by BlackRock
Results for ""
Market Outlooks
Is This Rebound for Real? And Is Now a Good Time to Double-Check Risk Tolerance?
This piece is approved to use with clients.
We take a closer look at the recent US stock market rally from its March low, and address some questions frequently asked by advisors around assessing risk and behavioral coaching in these unusual times.
Market Outlooks
‘Essential Businesses’: Managing Focused Stock Portfolios in a COVID-19 World
This piece is approved to use with clients.
Our equity portfolio managers talk about how they're navigating the COVID-19 crisis and their outlook.
Market Outlooks
U.S. vs. International Stocks: Will Next Decade’s Performance Look Different From the Last?
This piece is approved to use with clients.
International equity markets have trailed the U.S. for more than a decade. Does that make this asset class an opportunity or a value trap? We describe why we think international markets are poised for outperformance.
Market Outlooks
After the Rebound, Is It Time to Sell?
This piece is approved to use with clients.
We believe markets have priced in a fairly optimistic economic recovery from the coronavirus crisis, but some markets have increased significantly, while others have lagged. Here’s our take on long-term opportunities.
Market Outlooks
Weekly Wire: Dr. Copper’s Prognosis
This piece is approved to use with clients.
When it comes to doctors, there are a lot. The list includes famous (real) ones like Jonas Salk, Neil deGrasse Tyson, Marie Curie; famous (fictional) ones like Dr. Evil, Meredith Grey, Marcus Welby; and famous doctors who really aren’t doctors but go by the title, including the late Jazz musician Dr. John and the great Julius “Dr. J” Erving (remember, Brinker Capital is a Philadelphia-based company).
Market Outlooks
Weekly Wire: With apologies to the Dave Brubeck Quartet, here’s our “Take Five”
This piece is approved to use with clients.
Even casual fans of jazz – which we believe to be the great American art form – can easily recognize the opening cords to The Dave Brubeck Quartet’s classic, “Take Five.” Released in 1959 and penned by the quartet’s alto saxophonist Paul Desmond, “Take Five” was the first jazz single to sell one million copies and is the biggest selling jazz single of all time. So, with apologies to the great Dave Brubeck and The Dave Brubeck Quartet, here is our “Take Five,” or five things we think are worth thinking about as we move into the second half of 2020.
Market Outlooks
How We’re Positioning Portfolios to Outperform
This piece is approved to use with clients.
President and Global Chief Investment Officer Daniel Needham explains how asset valuation allows us to calculate expected returns for the long-term.
Market Outlooks
Our Valuation-Driven Asset Allocation Views Looking Beyond COVID-19
This piece is approved to use with clients.
While we haven’t faced a global pandemic of this kind before and the path to normalization is uncertain, we are encouraged by the aggressive policy response from central banks and governments which we think will be effective in averting a financial crisis. Thus, we think the recent sell-off has created significant opportunities for long-term investors like us. Read our commentary to learn our latest thinking.
Market Outlooks
Where We See Opportunities Ahead
This piece is approved to use with clients.
The news today makes the short-term economic outlook uncertain. Yet, we invest for the long term, not just for the next few months or even years. Given the attractive valuations we saw near the end of the first quarter, we think long-term returns look much better for investors now than they did just three months ago.
Please join our discussion with President and Global Chief Investment Officer Daniel Needham, Co-Head of Target Risk Strategies Dan McNeela, and Head of US Equity Strategies Michael Corty.
Market Outlooks
Weekly Wire: Pick a letter, any letter
This piece is approved to use with clients.
We got our first look at Q1 Gross Domestic Product last week, and as expected, it wasn’t pretty. While the Q1 GDP number is subject to revision, it showed the economy contracted (4.8%) Q to Q.